Cargando…
Peptide-Drug Conjugates: A New Hope for Cancer Management
Cancer remains the leading cause of death worldwide despite advances in treatment options for patients. As such, safe and effective therapeutics are required. Short peptides provide advantages to be used in cancer management due to their unique properties, amazing versatility, and progress in biotec...
Autores principales: | Chavda, Vivek P., Solanki, Hetvi K., Davidson, Majid, Apostolopoulos, Vasso, Bojarska, Joanna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9658517/ https://www.ncbi.nlm.nih.gov/pubmed/36364057 http://dx.doi.org/10.3390/molecules27217232 |
Ejemplares similares
-
Antibody–Biopolymer Conjugates in Oncology: A Review
por: Chavda, Vivek P., et al.
Publicado: (2023) -
The Vaccine World of COVID-19: India’s Contribution
por: Chavda, Vivek P., et al.
Publicado: (2022) -
Tirzepatide, a New Era of Dual-Targeted Treatment for Diabetes and Obesity: A Mini-Review
por: Chavda, Vivek P., et al.
Publicado: (2022) -
Smart therapies against global pandemics: A potential of short peptides
por: Apostolopoulos, Vasso, et al.
Publicado: (2022) -
Omicron variant (B.1.1.529) of SARS-CoV-2: Threat for the elderly?
por: Chavda, Vivek P, et al.
Publicado: (2022)